AAREYDRUGS₹106.73-3.33%
47/100
0100 · strongest
moderate
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %AAREYDRUGS financial summary
For Mar 2026, Aarey Drugs & Pharmaceuticals Ltd reported revenue of ₹472 crore, which fell 0.4% from the previous year. Net profit was ₹4 crore, which grew 0.0% year on year, on an operating margin of 2%. Earnings per share came in at ₹1.4. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹472 crore |
|---|---|
| Net profit | ₹4 crore |
| Operating margin | 2% |
| EPS | ₹1.4 |